pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

NCT05799144 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Oropharyngeal Carcinoma
Recurrent Oropharyngeal Carcinoma

Interventions

BIOLOGICAL: DNA Vaccine
BIOLOGICAL: Human Papillomavirus Tumor Antigen Vaccine
BIOLOGICAL: Pembrolizumab
PROCEDURE: Computed Tomography (CT)
PROCEDURE: Magnetic Resonance Imaging (MRI)
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Biopsy

Sponsor

Michael K. Gibson